Daily Dose Strongly Associated With Opioid-Related Mortality Among Nonmalignant Pain Patients

Pain Management

Patients who take daily doses of opioids for nonmalignant pain are at higher risk of opioid-related mortality, especially if daily doses exceed clinically recommended thresholds, according to research published in the Archives of Internal Medicine.

Researchers assessed a population of more than 607,000 patients, aged 15-64 years, who were prescribed an opioid from Aug. 1997-Dec. 2006 for nonmalignant pain. They identified 498 patients whose deaths were associated with their opioid prescription and 1,714 matched controls. Their analysis showed that an average daily opioid dose of 200 mg or more of morphine was connected to a three-fold increased risk of opioid-related mortality. Intermediate opioid doses (50-99 mg of morphine) still showed significantly increased risk of opioid-related mortality.

Read the study about opioid-related mortality among nonmalignant pain patients.

Read other coverage about pain management:

- Florida's Surgeon General Signs Prescription Drug Monitoring Program Into Effect

- Multi-Pronged Therapy Including Spinal Decompression Reduces Chronic Back Pain

- Florida's Riviera Beach Places Two-Year Moratorium on Pain Centers

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Most Read - Pain Management

Featured Webinars

Featured Whitepapers